Dehydroep:androsterone sailcylate useful against skin atrophy
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 7, 1998
Grant Date -
N/A
app pub date -
Sep 12, 1995
filing date -
Sep 12, 1995
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Disclosed is the use of dehydroepiandrosterone salicylate in the treatment of skin atrophy. ##STR1## Such types skin atrophy to be treated include the thinning and/or general degradation of the dermis often characterized by a decrease in collagen and/or elastin as well as decreased number, size and doubling potential of fibroblast cells.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully